Numerai Gp LLC Pacific Biosciences Of California, Inc. Transaction History

Numerai Gp LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $90,706 - $247,124	25,769 New	25,769 $96.6 Million
Q3 2023 Nov 13, 2023	SELL	$8.23 - $13.93 $859,886 - $1.46 Million	-104,482 Reduced 35.89%	186,635 $1.56 Billion
Q2 2023 Aug 11, 2023	BUY	$9.97 - $14.05 $2.9 Million - $4.09 Million	291,117 New	291,117 $3.87 Billion

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

Stay updated on Numerai Gp LLC with notifications on news.